Michael Albeck
#18,424
Most Influential Person Now
Israeli chemist
Michael Albeck's AcademicInfluence.com Rankings
Download Badge
Chemistry
Michael Albeck's Degrees
- Bachelors Chemistry Tel Aviv University
- Masters Chemistry Tel Aviv University
- PhD Chemistry Technion – Israel Institute of Technology
Why Is Michael Albeck Influential?
(Suggest an Edit or Addition)According to Wikipedia, Michael Albeck is an Israeli organic and bioorganic chemist of tellurium compounds. He was President of Bar-Ilan University from 1986 to 1989. Biography Michael Albeck was born in Berlin, Germany to Hanoch and Henya Albeck in October 1934. His family immigrated to Israel in 1935 and settled in Jerusalem. He earned both MSc in Chemistry and PhD from The Hebrew University of Jerusalem.
Michael Albeck's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intracranial pressure and cerebrospinal fluid outflow conductance in healthy subjects. (1991) (190)
- A new immunomodulating compound (AS-101) with potential therapeutic application (1987) (164)
- Anti-IL-10 Therapeutic Strategy Using the Immunomodulator AS101 in Protecting Mice from Sepsis-Induced Death: Dependence on Timing of Immunomodulating Intervention1 (2002) (136)
- Risk of infection after cerebrospinal fluid shunt: An analysis of 884 first-time shunts (2005) (126)
- Age dependency of resistance to cerebrospinal fluid outflow. (1998) (118)
- Ammonium Trichloro(dioxoethylene-o,o′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop (2004) (101)
- Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types (2005) (93)
- Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101. (1996) (91)
- Tellurium Compounds: Selective Inhibition of Cysteine Proteases and Model Reaction with Thiols (1998) (88)
- A Comparison Between Ventriculo-Peritoneal and Ventriculo-Atrial Cerebrospinal Fluid Shunts in Relation to Rate of Revision and Durability (1998) (76)
- Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels. (1997) (75)
- Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models (2007) (64)
- Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. (1995) (64)
- Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice. (2009) (59)
- Computerized infusion test compared to steady pressure constant infusion test in measurement of resistance to CSF outflow (2005) (59)
- Redox modulation of adjacent thiols in VLA-4 by AS101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state. (2014) (56)
- The organotellurium compound ammonium trichloro(dioxoethylene‐0,0′) tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice (2007) (56)
- The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent. (1992) (55)
- Protective and restorative role of AS101 in combination with chemotherapy. (1991) (54)
- Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras‐dependent up‐regulation of KGF expression (2004) (52)
- The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFκB signaling pathway and nitric oxide induction in macrophages (2010) (51)
- Synergistic anti‐tumoral effect of paclitaxel (taxol)+AS101 in a murine model of B16 melanoma: Association with ras‐dependent signal‐transduction pathways (2000) (48)
- A Controlled Comparison of Myelography, Computed Tomography, and Magnetic Resonance Imaging in Clinically Suspected Lumbar Disc Herniation (1995) (47)
- Diagnostic value of electrophysiological tests in patients with sciatica. (2000) (46)
- Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process. (2006) (46)
- Inhibition of Interleukin-10 by the Immunomodulator AS101 Reduces Mesangial Cell Proliferation in Experimental Mesangioproliferative Glomerulonephritis (2004) (42)
- The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway. (2006) (41)
- Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate. (1995) (39)
- Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101. (2003) (37)
- A critical assessment of clinical diagnosis of disc herniation in patients with monoradicular sciatica (2005) (37)
- Radioprotective effects of the immunomodulator AS101. (1990) (35)
- Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury. (2009) (33)
- Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin. (1990) (31)
- Up-regulation by ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101. (1998) (29)
- The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma. (1996) (29)
- Unbiased and efficient estimation of total ventricular volume of the brain obtained from CT-scans by a stereological method (2004) (29)
- The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme. (2007) (28)
- Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101). (1993) (28)
- Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium‐based compound, AS101 (2008) (26)
- The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice. (1998) (26)
- Multifunctional Activity of a Small Tellurium Redox Immunomodulator Compound, AS101, on Dextran Sodium Sulfate-induced Murine Colitis* (2014) (26)
- Octa‐O‐bis‐(R,R)‐Tartarate Ditellurane (SAS)—a Novel Bioactive Organotellurium(IV) Compound: Synthesis, Characterization, and Protease Inhibitory Activity (2007) (23)
- Toxicity study in rats of a tellurium based immunomodulating drug, AS-101: A potential drug for AIDS and cancer patients (2004) (23)
- Topical treatment for human papillomavirus‐associated genital warts in humans with the novel tellurium immunomodulator AS101: assessment of its safety and efficacy (2009) (22)
- The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action. (1993) (22)
- The biological activity and immunotherapeutic properties of AS-101, a synthetic organotellurium compound. (1988) (21)
- cis-3,5-Dibenzylidene-1,2,4-tritellurole, a novel organotellurium heterocycle (1982) (21)
- Tellurium Compound AS101 Induces PC12 Differentiation and Rescues the Neurons from Apoptotic Death (2003) (20)
- Part II: The Influence of Functional Groups and the Nature of the Yellowing (1965) (20)
- Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane–Induced Death by AS101 via Inhibition of the VLA-4–IL10–Survivin Axis (2014) (19)
- In vitro and in vivo activity of AS101 against West Nile virus (WNV). (2012) (19)
- Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model (2007) (19)
- Synthesis and Properties of Ammonium Trichloro(dioxyethylene-O,O′)tellurate (AS-101). A New Immunomodulating Compound (1989) (19)
- Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro. (1992) (18)
- Organotellurium chemistry. cis- and trans-2, 6-Diphenyl-1,4-ditellurafulvenes (1981) (17)
- Synergism between AS101 and PMA in lymphokine production. (1990) (17)
- In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin. (1992) (17)
- The organotellurium compound ammonium trichloro(dioxoethylene‐o,o′)tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice (2007) (17)
- The effect of the immunomodulator agent AS101 on interleukin‐2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti‐DNA antibody (1990) (16)
- Fracture of the lumbar vertebral ring apophysis imitating disc herniation (2005) (16)
- Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake. (2007) (16)
- Induction therapy in a multiple myeloma mouse model using a combination of AS101 and melphalan, and the activity of AS101 in a tumor microenvironment model. (2009) (15)
- The electrochemistry of tellurium in methylene chloride (1984) (15)
- Mechanism of radioprotection conferred by the immunomodulator AS101. (1993) (14)
- Ligand exchange processes in tetraalkoxytelluranes (1994) (14)
- Use and mechanism of action of AS101 in protecting bone marrow colony forming units-granulocyte-macrophage following purging with ASTA-Z 7557. (1991) (14)
- The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101. (2009) (14)
- The electrochemistry of organotellurium compounds—II. The electrochemistry of tellurides, diorganyltellurium dichlorides and diperchlorates (1983) (14)
- Upregulation of carp GDNF mRNA by the immunomodulator AS101. (2006) (13)
- The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment. (1992) (12)
- The electronic states of TeO2 (1988) (11)
- Identification of tellurium-containing compounds by means of mass spectrometry (1975) (11)
- Immunomodulatory effects of AS101 on interleukin-2 production and T-lymphocyte function of lymphocytes treated with psoralens and ultraviolet A. (1992) (11)
- [ROC-curve analysis. A statistical method for the evaluation of diagnostic tests]. (1990) (11)
- Reactions of tellurium(IV) halides with anthracene and other organic compounds (1975) (10)
- 778. Anionic polymerisation of vinyl monomers with butyl-lithium (1959) (10)
- Poly(p‐phenylene selenide): Synthesis and conductivity studies (1983) (10)
- Measurement of Resistance to CSF Outflow — Clinical Experiences in 333 Patients (1989) (10)
- A potential antimicrobial treatment against ESBL-producing Klebsiella pneumoniae using the tellurium compound AS101 (2009) (10)
- Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice. (1995) (10)
- Increased DNA repair ability after irradiation following treatment with the immunomodulator AS101. (1993) (10)
- The electrochemistry of organotellurium compounds—IV. The electrochemistry of diphenyl ditelluride and difuryl ditelluride in methylene chloride (1984) (9)
- The effect of nimodipine on ICP and CBF in patients with normal-pressure hydrocephalus (2005) (9)
- The electrochemistry of organotellurium compounds. I: The class of aryltellurium trichlorides (1983) (9)
- Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties. (1995) (9)
- Novel Involvement of the Immunomodulator AS101 in IL‐10 Signaling, via the Tyrosine Kinase Fer (2007) (9)
- The electrochemistry of organotellurium compounds—III. The electrochemistry of triphenyltellurium chloride (1984) (9)
- Part I: A New Method for the Determination of Yellowing (1965) (9)
- Electroinitiated polymerization of vinylic monomers in polar systems. I. Contribution of the electrolysis of methanol to free‐radical polymerization (1971) (8)
- Effect of the new immunoregulator AS-101 on in vitro functions of mononuclear cells from patients with systemic lupus erythematosus. (1989) (8)
- Diagnostic imaging in fracture of lumbar vertebral ring apophyses. (1992) (8)
- Formation of benzylic chlorides by rearrangement of cycloheptatrienes with tellurium tetrachloride (1983) (7)
- Distinction Between Homozygous and Heterozygous Subjects with Hereditary Haemochromatosis Using Iron Status Markers and Receiver Operating Characteristic (ROC) Analysis (1995) (7)
- Computerized Infusion Test Compared to Conventional Lumbo-Ventricular Perfusion for Measurement of Resistance to CSF-Outflow (1993) (7)
- Reproducibility and Reliability of Measurement of Resistance to CSF Outflow by Subarachnoid Perfusion (1989) (7)
- Ligand-Substitution Reactions of the Tellurium Compound AS-101 in Physiological Aqueous and Alcoholic Solutions. (2016) (7)
- Aromatization of unsaturated cyclohydrocarbons and halocyclohydrocarbons by tellurium tetrachloride (1979) (7)
- TeCl4 in organic synthesis. Elimination reactions (1991) (7)
- Electroinitiated polymerization of vinylic monomers in polar systems. III. Polymerization of acrylates and methacrylates in alcohol solutions (1971) (7)
- Effect of UVB and AS101 on interleukin-2 production and helper activity in psoriatic patients. (1993) (6)
- The effect of ketanserin on ICP and CBF in patients with normal-pressure hydrocephalus. (1996) (6)
- Diagnostic Imaging in Fracture of Lumbar Vertebral Ring Apophyses (1992) (6)
- Contrast enhanced computed tomography and magnetic resonance imaging in the diagnosis of recurrent disc herniation (2005) (6)
- Fluoride Ion as a Catalyst for Michael Additions to Nitro-Alkenes (1975) (6)
- Octa-O-bis-(R,R)-Tartarate Ditellurane (SAS) - A Novel Bioactive Organotellurium(IV) Compound: Synthesis, Characterization, and Protease Inhibitory Activity. (2008) (5)
- CYCLOBUTANE-BICYCLOBUTANE SYSTEM. 2. PROTONATION, DEPROTONATION, AND INTERMEDIATE CARBANION STEREOCHEMISTRY IN THE 1,3-HYDROCHLORIC ACID ELIMINATION FROM 3-CHLOROCYCLOBUTANECARBONITRILE (1979) (5)
- Inhibition of B16 melanoma metastasis by the immunomodulator AS101. (1996) (5)
- Patient attitudes to myelography, computed tomography and magnetic resonance imaging when examined for suspected lumbar disc herniation (2005) (4)
- Electroinitiated polymerization of vinylic monomers in polar systems. II. Polymerization of ethyl methacrylate in methanol solutions (1971) (4)
- [Surgery for lumbar disc prolapse on an outpatient basis]. (2005) (4)
- Mass Spectrometric Study of Some Organotellurium(IV) Compounds (1997) (4)
- The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesions. (1995) (4)
- Magnetic resonance imaging, computed tomography, and myelography in the diagnosis of recurrent lumbar disc herniation (2005) (4)
- Anionic polymerization of vinyl monomers: A demonstration (1958) (4)
- Calcium oxide-catalyzed reactions of menthadienes (1971) (4)
- TeCl4 as a catalyst in cationic oligomerisations and polymerisations (1982) (3)
- Developmental Study of Chick D2 (1983) (3)
- Comparison of Resistance to Outflow (Rout) Measured by Ventricular and Lumbar Perfusion (1989) (2)
- E1cB eliminations. Substituent and solvent effects on the E1cB elimination of the second type from 2-aryl-1,1,2-tricyanopropanes (1972) (2)
- Ocular inflammation stimulated by the immunomodulator AS101 [ammonium trichloro(dioxyethelene-O-O') tellurate]. (1994) (2)
- [Frequency of infections after shunting of hydrocephalus. An analysis of 884 shunts]. (1997) (2)
- E1cB and E2cB mechanisms in the elimination of trifluoroethoxide ion from α,α-dinitro-β,β-diphenyl-β-(trifluoroethoxy)ethanide anion and the non-reactivity of the β-cyano-α,α-dinitro-β,β-diphenylethanide anion (1975) (2)
- Characterization of four Chick Brain Synaptic Membrane Proteins (1982) (2)
- The Effect of Nimodipine on ICP and CBF in the Awake Patient (1989) (2)
- Synergistic antitumoral effect of the immunomodulator AS101 + paclitaxel (Taxol) (2000) (2)
- An apparatus for investigation of heterogeneous reactions in a flow system (1970) (2)
- [Symptomatic perineural cysts]. (2005) (2)
- Synthesis and structure of novel heterocyclic aminotelluranes (1997) (2)
- [Diagnostic imaging in suspected lumbar disk prolapse. A controlled comparison of myelography, CT and magnetic resonance imaging]. (1996) (1)
- Anodic stripping of tellurium in methylene chloride (1985) (1)
- Electroinitiated oligomerization of methyl acrylate in methanol solution (1975) (1)
- A very slow ElcB elimination under extreme ElcB conditions (1972) (1)
- Influence of applied electric fields on the free radical copolymerization of methylmethacrylate and styrene. An unusual decomposition of benzoylperoxide (1978) (1)
- Synergistic Antitumor Effect of the Immunomodulator AS101 and Taxol (1995) (1)
- Reactions between solids. V. Uncatalysed, catalysed and inhibited reaction of potassium chlorate with polydivinylbenzene (2007) (1)
- Electrochemical decomposition of biformylperoxide. A quantum mechanical calculation (1978) (1)
- Antioxidant made from plant material and process for obtaining same (1987) (0)
- Synthesis and Properties of Ammonium Trichloro(dioxyethylene-O,O′)tellurate (AS-101) (III). A New Immunomodulating Compound. (1990) (0)
- TeCl4 in Organic Synthesis. Elimination Reactions. (1992) (0)
- Therapeutic methods, and pharmaceutical compositions tilbehandling of warts with tellurium (2005) (0)
- Antioxidant compositions and methods for their use. (1987) (0)
- A pharmaceutical composition for inducing production of cytokines (1990) (0)
- Antitumor Effects of AS 101 Melanoma Cells : Implications for the ( AS 101 ) of Fas / Apo-1 Expression on B 16 ) Tellurate ′ Trichloro ( Dioxoethylene-0 , 0 Up-Regulation by Ammonium (1998) (0)
- The immunomodulator, ammonium trichloro[1,2-ethanediolato-O,O']-tellurate, suppresses the propagation of herpes simplex virus 2 by reducing the infectivity of the virus progeny. (2015) (0)
- Oxidation Resistant, edible fat compositions containing an extracted from plant tissue, active oxidation preventing agent. (1986) (0)
- [Muscular pain as the main symptom in hypokalemia]. (1987) (0)
- Immunomodulator AS101 potentiates apoptosis on Ha-Ras transformed cells which correlates with suppression of a survival protein Akt (48.20) (2007) (0)
- A method and means for reducing the development of tumors by means of a combination of a taxane compound and a tellurium and / or selenium compound (1995) (0)
- Sensitizing Band T-cell Lymphoma Cells to Paclitaxel / Abraxane – Induced Death by AS 101 via Inhibition of the VLA-4 – IL 10 – Survivin Axis (2015) (0)
- In Response: Letters (1996) (0)
- Process for the preparation of therapeutically useful complex telluuripitoisen (1989) (0)
- FLUORIDE ION AS A CATALYST FOR MICHAEL ADDITION TO NITRO‐ALKENES (1975) (0)
- Reactions between solids. IV. Reaction of sodium perchlorate, potassium bromate and potassium iodate with polydivinylbenzene (2007) (0)
- Platelets, granulocytes and hair growth factor effect of the new immunomodulator AS101 in chemotherapy treated lung cancer patients (1993) (0)
- Antiviral effect of The ImmunomodulatorAS101 on West Nile Virus by AlphaVBeta3 integrin inhibition (47.33) (2007) (0)
- IMMUNOCHEMICAL STUDIES OF SYNAPTIC MEMBRANE PROTEINS FROM CHICK BRAIN (1980) (0)
- Method of treatment of alopecia. (1993) (0)
- Antioxidantkompositioner Science anvaendning of the year. (1986) (0)
- The immunomodulator AS101 abrogates DSS-induced Colitis (2014) (0)
- Mechanism of the antitumor effect of the immunodmodulator AS101 and prevention by AS101 of bone-marrow toxicity when administered with taxol (1997) (0)
- What is MTD (1993) (0)
- Poster Sessions BP05: Parkinson's Disease (2003) (0)
- 584 Mesothelioma: Treatment with a new immunomodulator—AS101 (1995) (0)
- [Percutaneous lumbar diskectomy]. (1996) (0)
- [Management of suspected cervical column fracture]. (2003) (0)
- This information is current as Timing of Immunomodulating Intervention from Sepsis-Induced Death: Dependence on Immunomodulator AS101 in Protecting Mice Anti-IL-10 Therapeutic Strategy Using the (2013) (0)
- Radioprotective effects of AS101 (1990) (0)
- Skin cosmetic composition oxidationshæmmende (1986) (0)
- Diagnostic value of electrophysiological tests in patients with sciatica (2000) (0)
- The Acute Effect of Nimodipine on Intracranial Pressure and Cerebral Blood Flow (1990) (0)
- ORGANOTELLURIUM CHEMISTRY. CIS- AND TRANS-2,6-DIPHENYL-1,4-DITELLURAFULVENES (1981) (0)
- Mass Spectrometric Study of Some OrganotelluriumIV Compounds (1997) (0)
- [Spondylodesis in lumbar spinal stenosis?]. (1994) (0)
- [Spinal surgery organization. Danish Society of Neurosurgery]. (2005) (0)
- E1CB AND E2CB MECHANISMS IN THE ELIMINATION OF TRIFLUOROETHOXIDE ION FROM ALPHA,ALPHA-DINITRO-BETA,BETA-DIPHENYL-BETA-(TRIFLUOROETHOXY)ETHANIDE ANION AND THE NON-REACTIVITY OF THE BETA-CYANO-ALPHA,ALPHA-DINITRO-BETA-,BETA-DIPHENYLETHA (1975) (0)
This paper list is powered by the following services:
Other Resources About Michael Albeck
What Schools Are Affiliated With Michael Albeck?
Michael Albeck is affiliated with the following schools:
